PIN OAK INVESTMENT ADVISORS INC - INTERCEPT PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
PIN OAK INVESTMENT ADVISORS INC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$3
+50.0%
1540.0%0.00%
+50.0%
Q2 2023$20.0%1540.0%0.00%0.0%
Q1 2023$20.0%1540.0%0.00%0.0%
Q4 2022$2
-99.9%
1540.0%0.00%
-33.3%
Q3 2022$2,0000.0%1540.0%0.00%
+50.0%
Q2 2022$2,000
-33.3%
1540.0%0.00%
-33.3%
Q1 2022$3,0000.0%1540.0%0.00%0.0%
Q4 2021$3,000
+50.0%
1540.0%0.00%
+50.0%
Q3 2021$2,000
-33.3%
1540.0%0.00%
-33.3%
Q2 2021$3,000
-25.0%
1540.0%0.00%0.0%
Q1 2021$4,0000.0%1540.0%0.00%0.0%
Q4 2020$4,000
-33.3%
1540.0%0.00%
-50.0%
Q3 2020$6,000
-14.3%
1540.0%0.01%0.0%
Q2 2020$7,000
-30.0%
1540.0%0.01%
-40.0%
Q1 2020$10,000
-47.4%
1540.0%0.01%
-33.3%
Q4 2019$19,000
+90.0%
1540.0%0.02%
+87.5%
Q3 2019$10,000
-16.7%
1540.0%0.01%
-11.1%
Q2 2019$12,000
-29.4%
1540.0%0.01%
-35.7%
Q1 2019$17,000
+6.2%
1540.0%0.01%0.0%
Q4 2018$16,000
-15.8%
1540.0%0.01%0.0%
Q3 2018$19,0001540.01%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Carmignac Gestion 2,028,192$229,389,0001.76%
Orbimed Advisors 1,037,000$117,285,0001.33%
BB BIOTECH AG 255,719$28,922,0000.95%
ALTRINSIC GLOBAL ADVISORS LLC 193,369$21,870,0000.74%
FALCON POINT CAPITAL, LLC 44,573$5,041,0000.67%
Rhenman & Partners Asset Management AB 30,000$3,393,0000.54%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 11,155$1,262,0000.48%
NATIONAL PLANNING CORP 52,400$5,888,0000.44%
HIGHFIELDS CAPITAL MANAGEMENT LP 364,232$41,195,0000.38%
SPHERA FUNDS MANAGEMENT LTD. 15,000$1,697,0000.33%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders